Cargando…
DRUGPATH – a novel bioinformatic approach identifies DNA-damage pathway as a regulator of size maintenance in human ESCs and iPSCs
Genetic and biochemical screening approaches often fail to identify functionally relevant pathway networks because many signaling proteins contribute to multiple gene ontology pathways. We developed a DRUGPATH-approach to predict pathway-interactomes from high-content drug screen data. DRUGPATH is b...
Autores principales: | Kovacic, Boris, Rosner, Margit, Schlangen, Karin, Kramer, Nina, Hengstschläger, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374489/ https://www.ncbi.nlm.nih.gov/pubmed/30760778 http://dx.doi.org/10.1038/s41598-018-37491-w |
Ejemplares similares
-
eIF3 controls cell size independently of S6K1-activity
por: Schipany, Katharina, et al.
Publicado: (2015) -
DRUGPATH: The Drug Gene Pathway Meta-Database
por: Jaundoo, Rajeev, et al.
Publicado: (2020) -
Genome-wide DNA methylation analysis reveals that mouse chemical iPSCs have closer epigenetic features to mESCs than OSKM-integrated iPSCs
por: Ping, Wangfang, et al.
Publicado: (2018) -
Mouse SCNT ESCs Have Lower Somatic Mutation Load Than Syngeneic iPSCs
por: Li, Zhe, et al.
Publicado: (2014) -
A comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs
por: Choi, Jiho, et al.
Publicado: (2015)